Minerva Neurosciences (NERV) Interest Coverage Ratio Growth (5y) (2019 - 2026)
Minerva Neurosciences (NERV) Interest Coverage Ratio Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Minerva Neurosciences | 195.10 Mn | 195.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.11% |
| Dec 31, 2025 | 51.71% |
| Dec 31, 2024 | 32.14% |
| Jun 30, 2024 | -93.38% |
| Sep 30, 2023 | -80.61% |
| Jun 30, 2023 | -19.80% |
| Dec 31, 2022 | -14.87% |
| Sep 30, 2022 | -36.66% |
| Mar 31, 2022 | -20.98% |
| Sep 30, 2021 | -167.00% |
| Jun 30, 2021 | -345.88% |
| Mar 31, 2021 | -34.83% |
| Dec 31, 2020 | -26.29% |
| Sep 30, 2020 | -21.17% |
| Jun 30, 2020 | 67.10% |
| Mar 31, 2020 | 23.80% |
| Dec 31, 2019 | -183.79% |
| Sep 30, 2019 | 65.63% |
| Jun 30, 2019 | -5.96% |